EconPapers    
Economics at your fingertips  
 

Details about László Gulácsi

Homepage:http://hecon.uni-corvinus.hu
Workplace:Egészségügyi Közgazdaságtan Tanszék (Department of Health Economics), Közgazdaságtudományi Kar (Faculty of Economics), Budapesti Corvinus Egyetem (Corvinus University of Budapest), (more information at EDIRC)

Access statistics for papers by László Gulácsi.

Last updated 2015-11-06. Update your information in the RePEc Author Service.

Short-id: pgu509


Jump to Journal Articles

Journal Articles

2014

  1. Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective
    The European Journal of Health Economics, 2014, 15, (1), 73-82 Downloads View citations (3)
  2. Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 1-4 Downloads
  3. Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 35-43 Downloads View citations (4)
  4. Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
    The European Journal of Health Economics, 2014, 15, (1), 45-52 Downloads
  5. Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
    The European Journal of Health Economics, 2014, 15, (1), 101-109 Downloads View citations (4)
  6. Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
    The European Journal of Health Economics, 2014, 15, (1), 53-64 Downloads View citations (1)
  7. Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
    The European Journal of Health Economics, 2014, 15, (1), 129-129 Downloads View citations (6)
  8. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
    The European Journal of Health Economics, 2014, 15, (1), 111-119 Downloads View citations (2)
  9. HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain
    The European Journal of Health Economics, 2014, 15, (7), 675-680 Downloads
  10. Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
    The European Journal of Health Economics, 2014, 15, (1), 13-25 Downloads View citations (10)
  11. Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
    The European Journal of Health Economics, 2014, 15, (1), 83-92 Downloads View citations (3)
  12. The link between past informal payments and willingness of the Hungarian population to pay formal fees for health care services: results from a contingent valuation study
    The European Journal of Health Economics, 2014, 15, (8), 853-867 Downloads View citations (2)
  13. Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 27-34 Downloads View citations (1)
  14. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
    The European Journal of Health Economics, 2014, 15, (1), 121-128 Downloads View citations (6)

2012

  1. Comparing cost-sharing practices for pharmaceuticals and health care services among four central European countries
    Society and Economy, 2012, 34, (2), 221-240 Downloads View citations (2)
  2. Health economics and health technology assessment in Central and Eastern Europe: a dose of reality
    The European Journal of Health Economics, 2012, 13, (5), 525-531 Downloads View citations (7)
  3. Preferences of Hungarian consumers for quality, access and price attributes of health care services — result of a discrete choice experiment
    Society and Economy, 2012, 34, (2), 293-311 Downloads View citations (5)

2011

  1. User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders
    Health Policy, 2011, 102, (2), 255-262 Downloads View citations (8)

2010

  1. Future challenges for health economics and health technology assessment of biological drugs
    The European Journal of Health Economics, 2010, 11, (3), 235-238 Downloads
  2. The disease burden of colorectal cancer in Hungary
    The European Journal of Health Economics, 2010, 10, (1), 35-40 Downloads View citations (2)

2009

  1. Quality management and patient safety: Survey results from 102 Hungarian hospitals
    Health Policy, 2009, 90, (2-3), 175-180 Downloads View citations (2)

2007

  1. The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience
    The European Journal of Health Economics, 2007, 8, (2), 83-88 Downloads
  2. Verseny az egészségügyben. Egyesült államokbeli és nyugat-európai példák
    (Competition in health care. US and West European examples)
    Közgazdasági Szemle (Economic Review - monthly of the Hungarian Academy of Sciences), 2007, LIV, (5), 480-498 Downloads
 
Page updated 2021-03-28